Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Researchers describe first functioning 'lipidome' of mouse macrophage

For the first time, scientists have described not only the identities and quantities of fat species in a living mammalian cell – in this case, a mouse macrophage or white blood cell – but they also report how these lipids react and change over time to a bacterial stimulus triggering the cell's immune response.

Writing in the December 17 issue of the Journal of Biological Chemistry, lead author Edward A. Dennis, PhD, distinguished professor of pharmacology, chemistry and biochemistry at the University of California San Diego School of Medicine, said the work culminates more than seven years of effort by scientists in LIPID MAPS, a national consortium of 12 research laboratories at nine "core" universities, medical research institutes and life sciences companies collaborating to study the structure and function of lipids. UC San Diego serves as lead institution and information clearinghouse. Dennis is principal investigator.

"This paper is the essence of what we originally proposed," said Dennis. "This is our big, initial study, though we've published many other papers and have more in the pipeline." All nine core facilities in LIPID MAPS participated in the study.

Until relatively recently, lipid research has not received the same degree of attention as, say, genes or proteins. But fats are indisputably crucial to cell operations and overall health. Lipids represent major structural and metabolic components of cells and perform essential functions, such as membrane construction, energy production and intracellular communications.

"They're also a key in virtually all diseases," said Dennis. "Any condition involving inflammation involves lipids. It's hard to think of a disease, including cancer, in which lipids don't play some role."

Likewise for the subject of the research: the mouse macrophage.

"It would have been simpler to do this with yeast or bacteria," said Dennis, "but the macrophage is found in every kind of mammalian tissue (under different names). It's a major player in the immune system."

Moreover, scientists were able to study natural macrophages obtained from a live, well-established mouse model, rather than relying upon cultured cells. The model could also be genetically modified to test various hypotheses.

Previous studies have produced increasingly expansive and detailed "parts lists" of lipids. In October, for example, Dennis and colleagues published a paper that identified and quantified almost 600 distinct fat species circulating in human blood.

The new paper goes further. It chronicles the activity of more than 400 fat species in a macrophage after exposure to an endotoxin – a molecule found on the surfaces of bacteria that is recognized by macrophages and which triggers the cell's infection-fighting functions.

Each hour for 24 consecutive hours, scientists measured minuscule increases or decreases of targeted lipids, an indication of greater or lesser activity.

"The result is a temporal model of infection at the level of a single cell," said Dennis.

Similar experiments were conducted with macrophages exposed to a statin (a popular class of cholesterol-lowering drugs) and with macrophages simultaneously exposed to both an endotoxin and a statin.

"We chose to use a statin because we know it blocks production of cholesterol (a type of lipid), but statins also produce some anti-inflammatory effects. We wanted to see what else happens. And in fact, we saw some unexpected changes in certain metabolites."

Metabolites are the players and products of metabolism – the set of chemical reactions in cells that produce and sustain life.

Dennis said the findings lay the foundation for on-going and future projects to eventually produce a human "lipidome," a complete inventory of all fat species in the human body and how they work together.

"We only have three more years of the LIPID MAPS project," Dennis said. "But this is really just the beginning."

Co-authors of the paper are Raymond A. Deems of the Department of Chemistry and Biochemistry at UC San Diego; Richard Harkewicz of Department of Pharmacology, UC San Diego School of Medicine; Oswald Quehenberger and Gary Hardiman of UCSD's Department of Medicine, School of Medicine; H. Alex Brown, Stephen B. Milne and David S. Myers of the Department of Pharmacology, Vanderbilt University School of Medicine; Christopher K. Glass of the UCSD's Department of Medicine and Department of Cellular and Molecular Medicine, School of Medicine; Donna Reichart of UCSD's Department of Cellular and Molecular Medicine, School of Medicine; Alfred H. Merrill, Jr., M. Cameron Sullards and Elaine Wang of the Schools of Biology, Chemistry and Biochemistry and the Petit Institute of Bioengineering and Bioscience at Georgia Institute of Technology; Robert C. Murphy of the Department of Pharmacology, University of Colorado Denver; Christian R.H. Raetz, Teresa Garrett, Ziqiang Guan and Andrea C. Ryan of Department of Biochemistry, Duke University Medical Center; David W. Russell, Jeffrey G. McDonald and Bonne M. Thompson of Department of Molecular Genetics, University of Texas Southwestern Medical Center; Walter A. Shaw of Avanti Polar Lipids, Inc; Manish Sud, Yihua Zhao, Shakti Gupta, Mano R. Maurya and Eoin Fahy of the San Diego Supercomputer Center and Shankar Subramaniam of Department of Chemistry and Biochemistry, the Department of Cellular and Molecular Medicine and the San Diego Supercomputer Center, all at UC San Diego.

Funding for this project was provided by the National Institute of General Medical Sciences' Large Scale Collaborative "Glue" grant.

Scott LaFee | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht Gene therapy shows promise for treating Niemann-Pick disease type C1
27.10.2016 | NIH/National Human Genome Research Institute

nachricht 'Neighbor maps' reveal the genome's 3-D shape
27.10.2016 | International School of Advanced Studies (SISSA)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>